PNC Financial Services Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-392
| Closed | -$2K | – | 4807 |
|
|
2022
Q1 | $2K | Hold |
392
| – | – | ﹤0.01% | 4255 |
|
|
2021
Q4 | $2K | Hold |
392
| – | – | ﹤0.01% | 4214 |
|
|
2021
Q3 | $2K | Hold |
392
| – | – | ﹤0.01% | 4159 |
|
|
2021
Q2 | $2K | Buy |
392
+174
| +80% | +$888 | ﹤0.01% | 4071 |
|
|
2021
Q1 | $2K | Hold |
218
| – | – | ﹤0.01% | 3986 |
|
|
2020
Q4 | $2K | Hold |
218
| – | – | ﹤0.01% | 3870 |
|
|
2020
Q3 | $0 | Hold |
218
| – | – | ﹤0.01% | 4096 |
|
|
2020
Q2 | $0 | Sell |
218
-9
| -4% | – | ﹤0.01% | 4091 |
|
|
2020
Q1 | $0 | Sell |
227
-71
| -24% | – | ﹤0.01% | 4099 |
|
|
2019
Q4 | $0 | Buy |
298
+70
| +31% | – | ﹤0.01% | 4143 |
|
|
2019
Q3 | $1K | Buy |
228
+116
| +104% | +$509 | ﹤0.01% | 3950 |
|
|
2019
Q2 | $0 | Sell |
112
-27
| -19% | – | ﹤0.01% | 4170 |
|
|
2019
Q1 | $0 | Buy |
139
+9
| +7% | – | ﹤0.01% | 4158 |
|
|
2018
Q4 | $0 | Buy |
130
+18
| +16% | – | ﹤0.01% | 4217 |
|
|
2018
Q3 | $2K | Hold |
112
| – | – | ﹤0.01% | 3981 |
|
|
2018
Q2 | $2K | Sell |
112
-880
| -89% | -$15.7K | ﹤0.01% | 4006 |
|
|
2018
Q1 | $12K | Buy |
992
+60
| +6% | +$726 | ﹤0.01% | 3651 |
|
|
2017
Q4 | $16K | Buy |
932
+52
| +6% | +$893 | ﹤0.01% | 3505 |
|
|
2017
Q3 | $22K | Hold |
880
| – | – | ﹤0.01% | 3353 |
|
|
2017
Q2 | $22K | Buy |
+880
| New | +$22K | ﹤0.01% | 3307 |
|